Boston Scientific (BSX) Announces Positive Data from First HeartLogic Trial in Predicting HF Decompression
Tweet Send to a Friend
Boston Scientific (NYSE: BSX) announced results from the first clinical trial evaluating the performance of the HeartLogic Heart Failure Diagnostic ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
